---
title: "TRAW Q1'26 Earnings: EPS estimate is (0.56) USD"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286552794.md"
description: "TRAW (Traws Pharma, Inc.) is set to announce its Q1'26 results on May 18, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q1'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.56) USD. Learn more details at .Revenue & EPS values are provided in USDQ1'25Q2'25Q3'25Q4'25Q1'26Revenue Reported57.00 K2.73 M———Revenue Estimate60.00 K60.00 K60.00 K——Revenue Surprise-5.00%+4455.00%-100.00%EPS Reported2.09(0.11)(0.34)(0.82) EPS Estimate(8.04)(8.75)(9.16)(1.22)(0.56) EPS Surprise+126.00%+98.74%+96.29%+33.00%DisclaimerSelect reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc."
datetime: "2026-05-15T11:00:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286552794.md)
  - [en](https://longbridge.com/en/news/286552794.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286552794.md)
---

# TRAW Q1'26 Earnings: EPS estimate is (0.56) USD

TRAW (Traws Pharma, Inc.) is set to announce its Q1'26 results on May 18, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).

For Q1'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.56) USD. Learn more details at .

**Revenue & EPS values are provided in USD**

Q1'25

Q2'25

Q3'25

Q4'25

Q1'26

**Revenue Reported**

57.00 K

2.73 M

—

—

—

**Revenue Estimate**

60.00 K

60.00 K

60.00 K

—

—

**Revenue Surprise**

\-5.00%

+4455.00%

\-100.00%

**EPS Reported**

2.09

(0.11)

(0.34)

(0.82)

**EPS Estimate**

(8.04)

(8.75)

(9.16)

(1.22)

(0.56)

**EPS Surprise**

+126.00%

+98.74%

+96.29%

+33.00%

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

### Related Stocks

- [TRAW.US](https://longbridge.com/en/quote/TRAW.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Traws Pharma reports Q1 net loss  on higher R&D expenses](https://longbridge.com/en/news/286553923.md)
- [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md)
- [Traws Pharma, Inc. 1Q 2026: Revenue $0 EPS $(0.53) — 10-Q Summary](https://longbridge.com/en/news/286555967.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Shah Capital Management Will Vote ‘No' Across Five Proposals On Novavax's June 18 Ballot - SEC Filing](https://longbridge.com/en/news/286565204.md)